Want to join the conversation?
$XLNX FY15 10-K: New products were 45% of total revenues, whereas mainstream was 31%, base was 21% and support was 3%. CDC accounted for 43% of total revenues, IAD 39% and BCA 15%. North America accounted for 31% of total revenues, Asia Pacific 39%, Europe 20% and Japan was 10% of total revenues.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?